Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenue:
Product revenue	$ 86	$ 0	$ 86	$ 0
Cost and expenses:
Cost of product revenue	279	0	279	0
Research and development	11,393	7,703	33,794	21,674
Selling, general and administrative	8,781	5,952	24,699	14,322
Total cost and expenses	20,453	13,655	58,772	35,996
Loss from operations	(20,367)	(13,655)	(58,686)	(35,996)
Other income (expense):
Interest income	1,001	976	3,385	1,804
Other expense	(19)	(1)	(47)	(8)
Total other income	982	975	3,338	1,796
Net loss	(19,385)	(12,680)	(55,348)	(34,200)
Comprehensive loss	$ (19,385)	$ (12,680)	$ (55,348)	$ (34,200)
Net loss per share, basic and diluted (in dollars per share)	$ (0.29)	$ (0.21)	$ (0.82)	$ (0.6)
Weighted average common shares outstanding, basic and diluted (in shares)	67,385	61,066	67,263	57,169